Format

Send to

Choose Destination
Trends Pharmacol Sci. 2007 Aug;28(8):390-6. Epub 2007 Jul 13.

GPCR functional selectivity has therapeutic impact.

Author information

1
Neurosciences Hospital, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7160, USA. richard_mailman@med.unc.edu

Abstract

Many in vitro data show that some ligands can cause the differential activation of signaling pathways mediated by a single receptor (termed 'functional selectivity'). It remains unclear, however, whether functionally selective properties are meaningful in vivo. Data obtained with experimental compounds that are functionally selective at the dopamine D2L receptor in vitro suggest that these properties might predict atypical behavioral actions. Moreover, the antipsychotic drug aripiprazole is commonly thought to be a D2 partial agonist, but data clearly show that aripiprazole is functionally selective in vitro. It is proposed that the effects of aripiprazole in animal models and humans can be reconciled only with its functionally selective D2 properties, not its partial D2 agonism. Together, these data provide support for the hypothesis that compounds with functionally selective properties in vitro are likely to have novel actions in vivo, opening doors to new avenues of drug discovery.

PMID:
17629962
PMCID:
PMC2958218
DOI:
10.1016/j.tips.2007.06.002
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center